AIMC Topic: Drug Discovery

Clear Filters Showing 441 to 450 of 1550 articles

De Novo Generation and Identification of Novel Compounds with Drug Efficacy Based on Machine Learning.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
One of the main challenges in small molecule drug discovery is finding novel chemical compounds with desirable activity. Traditional drug development typically begins with target selection, but the correlation between targets and disease remains to b...

Generative artificial intelligence empowers digital twins in drug discovery and clinical trials.

Expert opinion on drug discovery
INTRODUCTION: The concept of Digital Twins (DTs) translated to drug development and clinical trials describes virtual representations of systems of various complexities, ranging from individual cells to entire humans, and enables in silico simulation...

HyperPCM: Robust Task-Conditioned Modeling of Drug-Target Interactions.

Journal of chemical information and modeling
A central problem in drug discovery is to identify the interactions between drug-like compounds and protein targets. Over the past few decades, various quantitative structure-activity relationship (QSAR) and proteo-chemometric (PCM) approaches have b...

PatentNetML: A Novel Framework for Predicting Key Compounds in Patents Using Network Science and Machine Learning.

Journal of medicinal chemistry
Patents play a crucial role in drug research and development, providing early access to unpublished data and offering unique insights. Identifying key compounds in patents is essential to finding novel lead compounds. This study collected a comprehen...

Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery.

Biomolecules
Molecular recognition is fundamental in biology, underpinning intricate processes through specific protein-ligand interactions. This understanding is pivotal in drug discovery, yet traditional experimental methods face limitations in exploring the va...

T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation study.

Journal of biomolecular structure & dynamics
Acquired resistance to EGFR is a major impediment in lung cancer treatment, highlighting the urgent need to discover novel compounds to overcome EGFR drug resistance. In this study, we utilized in silico methods and bioactivity evaluation for drug di...

Deep learning algorithms applied to computational chemistry.

Molecular diversity
Recently, there has been a significant increase in the use of deep learning techniques in the molecular sciences, which have shown high performance on datasets and the ability to generalize across data. However, no model has achieved perfect performa...

Adaptive Transfer of Graph Neural Networks for Few-Shot Molecular Property Prediction.

IEEE/ACM transactions on computational biology and bioinformatics
Few-Shot Molecular Property Prediction (FSMPP) is an improtant task on drug discovery, which aims to learn transferable knowledge from base property prediction tasks with sufficient data for predicting novel properties with few labeled molecules. Its...

A Deep Learning Approach to the Prediction of Drug Side-Effects on Molecular Graphs.

IEEE/ACM transactions on computational biology and bioinformatics
Predicting drug side effects before they occur is a critical task for keeping the number of drug-related hospitalizations low and for improving drug discovery processes. Automatic predictors of side-effects generally are not able to process the struc...